A drug development study for a periodontal disease : Biological properties of synthetic lipid A of Porphyromonas gingivalis lipopolysaccharide

牙周病药物开发研究:牙龈卟啉单胞菌脂多糖合成脂质A的生物学特性

基本信息

  • 批准号:
    17592170
  • 负责人:
  • 金额:
    $ 2.3万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2005
  • 资助国家:
    日本
  • 起止时间:
    2005 至 2006
  • 项目状态:
    已结题

项目摘要

A pentaacyl and diphosphoryl lipid A molecule (J Bacteriol 1995: 177: 2098) found in the lipid A isolated from P. gingivalis LPS was chemically synthesized, and its characteristics were evaluated to reconfirm its interesting bioactivities including low endotoxicity and activity against LPS-unresponsive C3H/HeJ mouse cells. The synthesized P. gingivalis lipid A (synthetic Pg-LA) exhibited strong activities almost equivalent to those of Escherichia coli-type synthetic lipid A (compound 506) in all assays on LPS-responsive mice, and cells. LPS and native lipid A of P. gingivalis displayed overall endotoxic activities, but its potency was reduced in comparison to the synthetic analogs. In the assays using C3H/HeJ mouse cells, the LPS and native lipid A significantly stimulated splenocytes to cause mitosis, and peritoneal macrophages to induce TNF-D and IL-6 production. However, synthetic Pg-LA and compound 506 showed no activity on the LPS-unresponsive cells. Inhibition assays using some i … More nhibitors including anti-human TLR 2 and TLR4/MD-2 complex monoclonal antibodies showed that the biological activity of synthetic Pg-LA was mediated only through the TLR4 signaling pathway that might act as a receptor for LPS, whereas TLR2, possibly together with CD14, was associated with the signaling cascade for LPS and native lipid A of P. gingivalis, in addition to the TLR4 pathway. These results suggested that the moderated and reduced biological activity of P. gingivalis LPS and native lipid A, including the activity on C3H/HeJ mouse cells by TLR2-mediated pathway, may be mediated by bioactive contaminants or low acylated molecules present in the native preparations having multiple lipid A moieties.In conclusion, these findings suggested that the moderated and reduced biological activity of P. gingivalis LPS and native lipid A, including the activity on C3H/HeJ mouse cells by TLR2-mediated pathway, may be mediated by bioactive contaminants or low acylated molecules present in the native preparations having high heterogeneity in lipid A moiety. To elucidate these problems, we are now attempting to evaluate the biological characterizations of tetra-acylated monophosphorylated or diphosphorylated species with the predominant molecules found in P. gingivalis native lipid A, using each chemically synthesized analog. Less
化学合成了从牙龈卟啉单胞菌LPS中分离的脂质A中发现的五酰基和二磷酰基脂质A分子(J Bacteriol 1995:177:2098),并评估了其特征,以重新确认其有趣的生物活性,包括低内毒性和对LPS无反应的活性C3 H/HeJ小鼠细胞。合成的牙龈卟啉单胞菌脂质A(合成的Pg-LA)在对LPS应答小鼠和细胞的所有测定中表现出几乎与大肠杆菌型合成脂质A(化合物506)相当的强活性。牙龈卟啉单胞菌的LPS和天然脂质A显示出总体内毒素活性,但与合成类似物相比,其效力降低。在使用C3H/HeJ小鼠细胞的测定中,LPS和天然脂质A显著刺激脾细胞以引起有丝分裂,并刺激腹膜巨噬细胞以诱导TNF-D和IL-6产生。然而,合成的Pg-LA和化合物506对LPS无反应的细胞没有显示出活性。抑制试验使用一些i ...更多信息 包括抗人TLR2和TLR4/MD-2复合物单克隆抗体的抑制剂显示,合成的Pg-LA的生物活性仅通过可能作为LPS受体的TLR4信号传导途径介导,而TLR2,可能与CD14一起,除了TLR4途径之外,还与LPS和牙龈卟啉单胞菌的天然脂质A的信号传导级联相关。这些结果表明,牙龈卟啉单胞菌LPS和天然脂质A的适度和降低的生物活性,包括通过TLR 2介导的途径对C3H/HeJ小鼠细胞的活性,可能是由具有多个脂质A部分的天然制剂中存在的生物活性污染物或低酰化分子介导的。这些发现表明牙龈卟啉单胞菌LPS和天然脂质A的生物活性,包括通过TLR2介导的途径对C3H/HeJ小鼠细胞的活性,可由脂质A部分具有高度异质性的天然制剂中存在的生物活性污染物或低酰化分子介导。为了阐明这些问题,我们现在正试图使用每种化学合成的类似物,评估具有牙龈卟啉单胞菌天然脂质A中发现的主要分子的四酰化单磷酸化或二磷酸化物质的生物学特性。少

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KUMADA Hidefumi其他文献

KUMADA Hidefumi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KUMADA Hidefumi', 18)}}的其他基金

Intranasal immunization of mice with P. gingivalis fimbriae and recombinant cholera toxin B subunit induces strong mucosal and systemic immune responses
用牙龈卟啉单胞菌菌毛和重组霍乱毒素 B 亚基鼻内免疫小鼠可诱导强烈的粘膜和全身免疫反应
  • 批准号:
    13671919
  • 财政年份:
    2001
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The study of structural factor of lipid A to mediate the activation of C3H/HeJ mice
脂质A结构因子介导C3H/HeJ小鼠活化的研究
  • 批准号:
    09670301
  • 财政年份:
    1997
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

IL-33/ST2信号转导通路对脂多糖诱导肺微血管内皮细胞旁通透性变化的影响及机制研究
  • 批准号:
    81171639
  • 批准年份:
    2011
  • 资助金额:
    58.0 万元
  • 项目类别:
    面上项目
Lipopolysaccharide 调节 Toll-like receptor 4 介导促进心肌样细胞存活时间的实验研究
  • 批准号:
    30872544
  • 批准年份:
    2008
  • 资助金额:
    27.0 万元
  • 项目类别:
    面上项目

相似海外基金

Disrupting Dogma: Investigating LPS Biosynthesis Inhibition as an Alternative Mechanism of Action of Aminoglycoside Antibiotics
颠覆教条:研究 LPS 生物合成抑制作为氨基糖苷类抗生素的替代作用机制
  • 批准号:
    10653587
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Microbiome-gut-brain dysfunction in prodromal and symptomatic Lewy body diseases
前驱期和症状性路易体病中的微生物组-肠-脑功能障碍
  • 批准号:
    10720677
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Gut microbiota-related mechanisms that impact colorectal cancer risk after bariatric surgery
影响减肥手术后结直肠癌风险的肠道微生物相关机制
  • 批准号:
    10733566
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Elucidation of anti-inflammatory mechanism of surface layer protein of lactic acid bacteria focusing on its interaction with lipopolysaccharide.
阐明乳酸菌表面层蛋白的抗炎机制,重点关注其与脂多糖的相互作用。
  • 批准号:
    23K13905
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
歯周病関連NASHにおけるNrf2の役割 - 歯周病原菌リポ多糖の腸肝連関に着目して
Nrf2在牙周病相关NASH中的作用——关注牙周病原菌脂多糖的肠肝联系
  • 批准号:
    23K07431
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Can circulating bile acids predict knee OA progression?
循环胆汁酸可以预测膝关节 OA 的进展吗?
  • 批准号:
    10575385
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Pathogenic mechanisms of heart failure induced by the chronic infusion of lipopolysaccharide derived from Porphylomonas gingivalis.
长期输注牙龈卟啉单胞菌脂多糖诱发心力衰竭的致病机制。
  • 批准号:
    23K09517
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Understanding the regulation of the intestinal epithelium in Alzheimer’s disease by commensal bacteria and the role it plays in preventing neurocognitive decline
了解共生细菌对阿尔茨海默病肠上皮的调节及其在预防神经认知衰退中的作用
  • 批准号:
    10680057
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Is the gut important in multiple joint osteoarthritis? A multimodal investigation in humans and pet dogs
肠道在多关节骨关节炎中重要吗?
  • 批准号:
    10859955
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
Role of Gut-Immune Interactions in Aging-Associated Bladder Cancer
肠道免疫相互作用在衰老相关膀胱癌中的作用
  • 批准号:
    10429068
  • 财政年份:
    2023
  • 资助金额:
    $ 2.3万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了